Clinical studies examining the impact of obesity on breast cancer risk and prognosis (Q38162118)

30 August 2017

title

Clinical studies examining the impact of obesity on breast cancer risk and prognosis (English)

1 reference

30 August 2017

0 references

2

Howard D Strickler

1 reference

30 August 2017

Rishi Jain

1

1 reference

30 August 2017

Eugene Fine

series ordinal

3

1 reference

30 August 2017

Joseph A Sparano

series ordinal

4

1 reference

30 August 2017

publication date

13 November 2013

1 reference

Journal of Mammary Gland Biology and Neoplasia

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

3-4

1 reference

30 August 2017

page(s)

257-266

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dual effects of weight and weight gain on breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity, mammography use and accuracy, and advanced breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Targeting insulin and insulin-like growth factor signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Metformin and breast cancer risk: a meta-analysis and critical literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The metabolic response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer

21 January 2018

1 reference

12 December 2020

Upper abdominal obesity, insulin resistance and breast cancer risk

1 reference

12 December 2020

Is obesity an independent prognosis factor in woman breast cancer?

1 reference

12 December 2020

Metabolic syndrome, hyperinsulinemia, and colon cancer: a review

1 reference

12 December 2020

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

12 December 2020

Prevalence of obesity in the United States, 2009-2010.

1 reference

12 December 2020

Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States)

1 reference

12 December 2020

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

1 reference

12 December 2020

The FACE trial: letrozole or anastrozole as initial adjuvant therapy?

1 reference

12 December 2020

Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer

1 reference

12 December 2020

Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients

1 reference

12 December 2020

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

12 December 2020

10.1007/S10911-013-9307-3

Identifiers

DOI

1 reference

30 August 2017

1 reference